½Ã°£ | ÇÁ·Î±×·¥ | ¿¬ÀÚ, ÁÂÀå |
---|---|---|
09:30~09:40 | °³È¸»ç | ÃÖº´¿Á(¼º±Õ°üÀÇ´ë, ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ ȸÀå) |
¥°. New tools for managing neuromuscular disorder | ÁÂÀå: ¹Ú±â´ö(ÀÌÈÀÇ´ë), ¹Î¾ç±â(ÇѸ²ÀÇ´ë) | |
09:40~10:10 | Neuroimaging biomarkers in neurodegenerative disease | ¹é¼³Èñ(°í·ÁÀÇ´ë) |
10:10~10:40 | Patient-reported outcome measures and telemonitoring in ALS | ¿ÀÁÖ¿¬(´Ü±¹´ëÇб³,°£È£´ëÇÐ) |
10:40~10:50 | Q & A | |
10:50~11:00 | Intermission | |
¥±. New Classification! New diagnostic procedure! New treatment! in myopathy | ÁÂÀå: ±Ç±âÇÑ(ÇѸ²ÀÇ´ë), ÃÖ¿µÃ¶(¿¬¼¼ÀÇ´ë) | |
11:00~11:20 | Novel classification of myositis | ÀÌÁ¾¸ñ(°æºÏÀÇ´ë) |
11:20~11:40 | Updated diagnostic approaches in myopathy (Antibody testing? Biopsy first or NGS first? Do biopsy or not?) |
±è½Â¿ì(¿¬¼¼ÀÇ´ë) |
11:40~12:00 | CAR-T Therapy in myositis | ½ÅÁ¦¿µ(ÇѸ²ÀÇ´ë) |
12:00~12:10 | Q & A | |
12:10~13:10 | Àӽà ÃÑȸ & Lunch | |
¥². Plenary Lecture | ÁÂÀå: ÃÖº´¿Á(¼º±Õ°üÀÇ´ë) | |
13:10~13:50 | Japan myasthenia gravis guideline and overview of relevant data for every biologics | Hiroyuki Murai (International University of Health and Welfare) |
13:50~14:00 | Q & A | |
14:00~14:10 | Intermission | |
¥³. Scientific Session | ÁÂÀå: ±è½ÂÇö(ÇѾçÀÇ´ë), ±èº´Á¶(°í·ÁÀÇ´ë) | |
14:10~14:25 | 1st (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®) | |
14:25~14:40 | 2nd (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®) | |
14:40~14:55 | 3rd (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®) | |
14:55~15:10 | 4th (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®) | |
¥´. Poster Session | ||
15:10~15:40 | Poster Session | |
¥µ. Research Highlight Track | ÁÂÀå: ±è»ó¹ü(°æÈñÀÇ´ë), ÀÓ¿µ¹Î(¿ï»êÀÇ´ë) | |
15:40~15:55 | 1st (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®) | |
15:55~16:10 | 2nd (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®) | |
16:10~16:25 | 3rd (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®) | |
16:25~ | ÄûÁî Ãß÷ ¹× Æóȸ»ç |